A first-of-its-kind study has been published that integrates genotype and epigenotype data across the entire genome.
Prednisone Might be the Missing Ingredient in the American College of Rheumatology’s Recommendations for Treating Patients with Rheumatoid Arthritis
A combination therapy with glucocorticoids may be the gold standard for treating patients with rheumatoid arthritis (RA)
Is Predisone 3 mg/day an Appropriate Dose for Patients with Rheumatoid Arthritis?
Long-term, low-dose prednisone at less than 5 mg/day appears tolerable and effective for many patients with rheumatoid arthritis (RA)
Why Oral Corticosteroids Should Not be Used in Patients with Rheumatoid Arthritis
Steroid use in patients with rheumatoid arthritis (RA) has been linked to higher mortality rates, greater rate of infections, more cases of pneumonia, and serious gastrointestinal events
ACR/ARHP Annual Meeting 2012: Genes Not the Only Factor in Susceptibility to Rheumatoid Arthritis
Epigenetics, innate immunity, and environmental stresses such as smoking could have more influence than scientists once believed
ACR/ARHP Annual Meeting 2012: Fatigue for People with Rheumatoid Arthritis Rooted in Physiological and Psychological Factors
Researchers find that genes, gender, and cognition all contribute to fatigue in rheumatoid arthritis (RA)
First Annual Rheumatoid Awareness Day to Be Held February 2
New day of action and outreach aims to spread awareness of rheumatoid arthritis
ACR/ARHP Annual Meeting 2012: Early Signs of Rheumatoid Arthritis May Appear Outside the Joints
Evidence that suggests rheumatoid arthritis (RA) starts in mucosal sites such as the oral cavity and lung may lead to improved treatment and prevention of the disease
Survivin Essential for the Maturation of Antigen Presenting Cells in Rheumatoid Arthritis Patients
In patients with RA, survivin is essential for the survival of leukocytes as they differentiate and mature into dendritic cells, thereby raising it as a potential therapeutic target.
ACR/ARHP Annual Meeting 2012: Late-Breaking Abstracts Bring Newer Research to the Forefront
Studies addressing rheumatoid arthritis (RA) flares, a potential new drug for psoriatic arthritis, and a novel agent in the treatment of active RA are among the highlights
- « Previous Page
- 1
- …
- 57
- 58
- 59
- 60
- 61
- …
- 74
- Next Page »